跳至主要内容
临床试验/JPRN-jRCT2080221705
JPRN-jRCT2080221705未知2 期

Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Proof of concept study

TOA EIYO LTD.0 个研究点目标入组 100 人开始时间: 2012年1月30日最近更新:
适应症

试验速览

阶段
2 期
发起方
TOA EIYO LTD.
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 79age old(—)
性别
All

入选标准

  • 1) Admission to hospital within 6 hrs of the onset of symptoms
  • 2) Chest pain lasting for >= 30 min
  • 3) ST-segment elevation of >= 0.2 mV in 2 or more contiguous precordial leads (V1-V4) on standard 12-lead electrocardiogram
  • 4) TIMI flow grade 0/1 in left anterior descending artery (LAD) on diagnostic coronary angiography (CAG)
  • 5) Written informed consent

排除标准

  • 1) Prior documented old myocardial infarction (MI) or a clinical history of definite MI
  • 2) Left main trunk (LMT) stenosis >50%
  • 3) Total occlusion of left circumflex artery (LCX) or right coronary artery (RCA)
  • 4) Left bundle-branch block
  • 5) Suspected acute aortic dissection
  • 6) Cardiac arrest or cardiogenic shock
  • 7) Thrombolytic therapy or coronary artery bypass grafting (CABG)
  • 8) Hepatic and/or renal dysfunction
  • 9) History of allergy or drug hypersensitivity
  • 10) Pregnancy or nursing mothers or childbearing women

研究者

发起方
TOA EIYO LTD.

相似试验